Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

792 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia.
Baker AH, Sica V, Work LM, Williams-Ignarro S, de Nigris F, Lerman LO, Casamassimi A, Lanza A, Schiano C, Rienzo M, Ignarro LJ, Napoli C. Baker AH, et al. Among authors: napoli c. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3597-602. doi: 10.1073/pnas.0611112104. Epub 2007 Feb 20. Proc Natl Acad Sci U S A. 2007. PMID: 17360688 Free PMC article.
Adenovirus serotype 5 hexon mediates liver gene transfer.
Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H, Pink R, Buckley SM, Greig JA, Denby L, Custers J, Morita T, Francischetti IM, Monteiro RQ, Barouch DH, van Rooijen N, Napoli C, Havenga MJ, Nicklin SA, Baker AH. Waddington SN, et al. Among authors: napoli c. Cell. 2008 Feb 8;132(3):397-409. doi: 10.1016/j.cell.2008.01.016. Cell. 2008. PMID: 18267072 Free article.
Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis.
de Nigris F, Lerman A, Ignarro LJ, Williams-Ignarro S, Sica V, Baker AH, Lerman LO, Geng YJ, Napoli C. de Nigris F, et al. Among authors: napoli c. Trends Mol Med. 2003 Aug;9(8):351-9. doi: 10.1016/s1471-4914(03)00139-4. Trends Mol Med. 2003. PMID: 12928037 Review.
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
Napoli C, Bruzzese G, Ignarro LJ, Crimi E, de Nigris F, Williams-Ignarro S, Libardi S, Sommese L, Fiorito C, Mancini FP, Cacciatore F, Liguori A. Napoli C, et al. Am Heart J. 2008 Dec;156(6):1154.e1-8. doi: 10.1016/j.ahj.2008.09.006. Am Heart J. 2008. PMID: 19033012 Clinical Trial.
Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
de Nigris F, D'Armiento FP, Somma P, Casini A, Andreini I, Sarlo F, Mansueto G, De Rosa G, Bonaduce D, Condorelli M, Napoli C. de Nigris F, et al. Among authors: napoli c. Int J Cardiol. 2001 Dec;81(2-3):107-15; discusssion 115-6. doi: 10.1016/s0167-5273(01)00542-3. Int J Cardiol. 2001. PMID: 11744122
792 results